CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 550 enrolled
Drug / intervention
Choose to Movebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05678985
NCT05678985N/ACompleted
CompareCT.gov

Choose to Move (Phase 4): Impact and Implementation Evaluation of a Program to Enhance Older Adult Physical Activity, Mobility and Health

University of British Columbia·interventional·Posted Jan 10, 2023·Updated Mar 27, 2025

In Brief

A clinical study evaluating Choose to Move for Aging and 5 related conditions. Completed, enrolled 550 participants across 1 site.

Detailed Summary

The objectives of this study are to: 1) evaluate whether Choose to Move (CTM) Phase 4 improves health outcomes in older adults who participate and 2) assess whether CTM Phase 4 is delivered as planned and what factors support or inhibit its delivery at scale. CTM Phase 4 is a 3-month, choice-based program for low active older adults being scaled-up across British Columbia (BC), Canada. The goals of CTM are to enhance physical activity, mobility and social connectedness in older adults living in BC, Canada.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAging, Mobility Limitation, Sedentary Behaviour, Loneliness, Social Isolation, Social Connectedness
CountriesCanada
CollaboratorsCanadian Institutes of Health Research (CIHR), Active Aging Society

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJan 10, 2023
Enrollment StartSep 17, 2020
Primary CompletionJan 29, 2025
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 3.5 years ago

Interventions

Choose to Movebehavioral

As described under study arm description.